A scientist by training, Ari obtained his Ph.D. from Loma Linda University’s Center for Perinatal Biology and completed his postdoctoral fellowship at Albert Einstein College of Medicine. Upon completing his scientific training, Ari joined the pharmaceutical industry with a focus on reproductive medicine and oncology. After a decade in pharma, he concluded his tenure at Merck & Co. During this time, Ari completed his MBA at Indiana University's Kelley School of Business. In 2011, he joined The Wonderful Company as Vice President of Clinical Development to develop consumer- and regulatory-relevant research and programming in support of a wide range of food and agricultural products. Ari joined PLUS Products in 2019 as their Chief Scientific Officer in order to focus his attention on cannabis-related chemistry and technologies. In 2020, Ari assumed leadership of PLUS’ Innovation Team and has helped usher Sleep and Strains, the company’s two newest product lines into the marketplace.
Programming descriptions are generated by participants and do not necessarily reflect the opinions of SXSW.